Stay updated with breaking news from Ucla Gi Oncology Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Treatment with GRANITE showed early signals of activity following frontline induction chemotherapy in metastatic microsatellite stable colorectal cancer.
Approval based on Phase III NAPOLI 3 clinical trial in which Onivyde® regimen demonstrated statistically significant superiority and clinically meaningful improvements in overall survival and...
13.02.2024 - Approval based on Phase III NAPOLI 3 clinical trial in which Onivyde regimen (NALIRIFOX) demonstrated statistically significant superiority and clinically meaningful improvements in overall survival and progression-free survival versus ...
Approval based on Phase III NAPOLI 3 clinical trial in which Onivyde® regimen (NALIRIFOX) demonstrated statistically significant superiority and clinically...
AMPLIFY-7P study builds on preliminary positive findings from the 2-peptide formulation of ELI-002 published in Nature Medicine demonstrating tumor biomarker reduction, with strong T cell responses...